Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

En+ Group reported for 9 months of 2024 by RAS

10/29/24 ENPG

Kvant collected the minimum amount of success

10/29/24 OTCI

Fesco to launch direct transportation between Russia and Tanzania

10/29/24 FESH

Fesco increased transportation between Vladivostok and China

10/29/24 FESH

Lenta reported for 9 months of 2024 by RAS

10/29/24 LENT

Lambumize IPO went under the bottom line

10/29/24 LMBZ

Lenzoloto reported for 9 months of 2024 by RAS

10/29/24 LNZL

Bashinformsvyaz reported for 9 months of 2024 by RAS

10/29/24 BISVP

VTB reports for 9 months of 2024 by RAS

10/29/24 VTBR

Gazprom reported for 9 months of 2024 by RAS

10/29/24 GAZP